Manning Paul B bought VRCA

November 25, 2025 · Form 4 insider transaction

Manning Paul B bought 343,845 shares of Verrica Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
343,845
Price
N/A
Total value
N/A
RoleDirector, 10% owner
SecuritySeries C Warrant (right to buy)
Transaction codeP: Open-market purchase
Transaction dateNovember 25, 2025
Filing dateNovember 25, 2025
Shares owned after343,845
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The reported securities are included within 1,375,380 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.; Immediately exercisable.; The shares are held by Mr. Manning jointly with his spouse.

View the original Form 4 on SEC EDGAR